PerkinElmer | For The Better

SARS-CoV-2 Solutions

Who We Are

What We Do

Markets We Serve

Fighting SARS-CoV-2 Together

Our complete workflows with standardized equipment and kits are available to help labs address their SARS-CoV-2 testing challenges.

Learn More

Our mission of innovating for a healthier world is at the heart of everything we do. We help customers make smarter decisions, earlier diagnoses, more effective treatments and scientific breakthroughs.

Learn More

Detection: Detect and identify disease, contaminants and biological pathways

Imaging: Visualize biological, cellular and clinical insights

Informatics: Unify, visualize and analyze your data

Services: Customized laboratory management, research and clinical solutions

Clinical: Screening and diagnostic solutions for earlier clinical insights

Life Sciences: Disease research, drug discovery and QA/QC for faster drugs to market

Environmental: Air, water and soil testing for a safer planet

Food: Food safety and quality testing for feeding a growing population

Industrial: Chemical and material testing for better products

Key Trends and Insights

PerkinElmer Has Acquired Horizon Discovery

By combining Horizon’s capabilities with PerkinElmer’s life science research and applied genomics portfolios, we will be able to deliver complete workflow solutions to our life science customers working on drug discovery and development. Specifically, Horizon’s innovative reagents, which leverage CRISPR technologies, will come together with PerkinElmer’s imaging, detection, automation and LabChip platforms to provide scalable workflows and quality control capabilities when working with engineered cells.

News